BOTHELL, Wash., Feb. 13 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will present at the Roth Capital Partners 20th Annual OC Growth Stock Conference on Wednesday, February 20, 2008 at the Ritz Carlton Laguna Nigel. Mike Matysik, the company's senior vice president and chief financial officer, will present the Company's business strategy and third quarter financial results at 8:30 a.m. Pacific Time.
Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation, which may be accessed at the Company's website at http://www.cardiacscience.com. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of
advanced diagnostic and therapeutic cardiology devices and systems,
including AEDs, electrocardiographs, stress test systems, Holter monitoring
systems, hospital defibrillators, cardiac rehabilitation telemetry systems,
and cardiology data management systems (informatics) that connect with
hospital information (HIS), electronic medical record (EMR), and other
information systems. The Company sells a variety of related products and
consumables, and provides a portfolio of training, maintenance, and support
services. Cardiac Science, the successor to the cardiac businesses that
established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and
Quinton(R) brands, is headquartered in Bothell, Washington. With customers
in more than 100 countries worldwide, the company has operations in North
America, Europe, and Asia. For information, call 425-402-2000 or visit
Cardiac Science Corporation
Sr. Vice President and CFO
Doug Sherk/Jenifer Kirtland
EVC Group, Inc.
EVC Group, Inc.
|SOURCE Cardiac Science Corporation|
Copyright©2008 PR Newswire.
All rights reserved